Sonova H Ag

SW:SOON Switzerland Medical Devices
Market Cap
$12.33 Billion
CHF11.29 Billion CHF
Market Cap Rank
#1452 Global
#6 in Switzerland
Share Price
CHF189.35
Change (1 day)
+0.40%
52-Week Range
CHF188.60 - CHF282.70
All Time High
CHF379.39
About

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hea… Read more

Sonova H Ag (SOON) - Net Assets

Latest net assets as of September 2025: CHF2.45 Billion CHF

Based on the latest financial reports, Sonova H Ag (SOON) has net assets worth CHF2.45 Billion CHF as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF5.51 Billion) and total liabilities (CHF3.06 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF2.45 Billion
% of Total Assets 44.43%
Annual Growth Rate 9.1%
5-Year Change -3.17%
10-Year Change 40.83%
Growth Volatility 17.13

Sonova H Ag - Net Assets Trend (2002–2025)

This chart illustrates how Sonova H Ag's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Sonova H Ag (2002–2025)

The table below shows the annual net assets of Sonova H Ag from 2002 to 2025.

Year Net Assets Change
2025-03-31 CHF2.68 Billion +7.76%
2024-03-31 CHF2.49 Billion +11.65%
2023-03-31 CHF2.23 Billion -8.28%
2022-03-31 CHF2.43 Billion -12.25%
2021-03-31 CHF2.77 Billion +36.62%
2020-03-31 CHF2.03 Billion -14.59%
2019-03-31 CHF2.38 Billion -3.99%
2018-03-31 CHF2.47 Billion +16.12%
2017-03-31 CHF2.13 Billion +11.80%
2016-03-31 CHF1.91 Billion +1.84%
2015-03-31 CHF1.87 Billion +5.49%
2014-03-31 CHF1.77 Billion +8.50%
2013-03-31 CHF1.64 Billion +10.80%
2012-03-31 CHF1.48 Billion +9.75%
2011-03-31 CHF1.34 Billion -4.52%
2010-03-31 CHF1.41 Billion +37.18%
2009-03-31 CHF1.03 Billion +11.70%
2008-03-31 CHF919.06 Million +2.72%
2007-03-31 CHF894.69 Million +43.26%
2006-03-31 CHF624.52 Million +38.87%
2005-03-31 CHF449.70 Million +28.36%
2004-03-31 CHF350.34 Million +20.62%
2003-03-31 CHF290.46 Million -19.73%
2002-03-31 CHF361.86 Million --

Equity Component Analysis

This analysis shows how different components contribute to Sonova H Ag's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1050.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Retained Earnings CHF2.67 Billion 100.10%
Common Stock CHF3.00 Million 0.11%
Total Equity CHF2.66 Billion 100.00%

Sonova H Ag Competitors by Market Cap

The table below lists competitors of Sonova H Ag ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sonova H Ag's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,470,400,000 to 2,664,600,000, a change of 194,200,000 (7.9%).
  • Net income of 540,500,000 contributed positively to equity growth.
  • Dividend payments of 256,200,000 reduced retained earnings.
  • Share repurchases of 67,300,000 reduced equity.
  • New share issuances of 29,200,000 increased equity.
  • Other comprehensive income increased equity by 611,700,000.
  • Other factors decreased equity by 663,700,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CHF540.50 Million +20.28%
Dividends Paid CHF256.20 Million -9.61%
Share Repurchases CHF67.30 Million -2.53%
Share Issuances CHF29.20 Million +1.1%
Other Comprehensive Income CHF611.70 Million +22.96%
Other Changes CHF-663.70 Million -24.91%
Total Change CHF- 7.86%

Book Value vs Market Value Analysis

This analysis compares Sonova H Ag's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.25x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 17.22x to 4.25x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-03-31 CHF11.00 CHF189.35 x
2003-03-31 CHF4.39 CHF189.35 x
2004-03-31 CHF5.27 CHF189.35 x
2005-03-31 CHF6.71 CHF189.35 x
2006-03-31 CHF9.26 CHF189.35 x
2007-03-31 CHF13.15 CHF189.35 x
2008-03-31 CHF13.44 CHF189.35 x
2009-03-31 CHF15.43 CHF189.35 x
2010-03-31 CHF21.05 CHF189.35 x
2011-03-31 CHF19.98 CHF189.35 x
2012-03-31 CHF21.99 CHF189.35 x
2013-03-31 CHF23.90 CHF189.35 x
2014-03-31 CHF25.95 CHF189.35 x
2015-03-31 CHF27.43 CHF189.35 x
2016-03-31 CHF28.50 CHF189.35 x
2017-03-31 CHF32.23 CHF189.35 x
2018-03-31 CHF37.41 CHF189.35 x
2019-03-31 CHF36.03 CHF189.35 x
2020-03-31 CHF31.28 CHF189.35 x
2021-03-31 CHF43.46 CHF189.35 x
2022-03-31 CHF38.44 CHF189.35 x
2023-03-31 CHF36.61 CHF189.35 x
2024-03-31 CHF41.32 CHF189.35 x
2025-03-31 CHF44.57 CHF189.35 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sonova H Ag utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 20.28%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 13.98%
  • • Asset Turnover: 0.65x
  • • Equity Multiplier: 2.22x
  • Recent ROE (20.28%) is above the historical average (19.61%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 11.85% 7.40% 0.78x 2.06x CHF6.65 Million
2003 -16.24% -8.51% 0.91x 2.10x CHF-75.74 Million
2004 19.80% 10.80% 0.93x 1.97x CHF34.09 Million
2005 21.22% 14.39% 0.89x 1.66x CHF50.24 Million
2006 27.72% 19.90% 0.93x 1.49x CHF110.24 Million
2007 27.11% 22.52% 0.85x 1.42x CHF152.51 Million
2008 29.98% 22.75% 0.95x 1.39x CHF182.70 Million
2009 27.80% 22.74% 0.88x 1.40x CHF181.92 Million
2010 25.30% 23.65% 0.62x 1.72x CHF214.58 Million
2011 17.25% 14.29% 0.74x 1.62x CHF97.06 Million
2012 16.74% 15.23% 0.71x 1.55x CHF99.35 Million
2013 6.90% 6.18% 0.67x 1.67x CHF-49.77 Million
2014 19.53% 17.47% 0.75x 1.49x CHF166.35 Million
2015 19.52% 17.69% 0.76x 1.46x CHF175.54 Million
2016 17.90% 16.27% 0.75x 1.46x CHF148.79 Million
2017 16.56% 14.58% 0.61x 1.87x CHF138.33 Million
2018 16.32% 15.12% 0.62x 1.75x CHF154.97 Million
2019 19.29% 16.43% 0.64x 1.82x CHF218.72 Million
2020 24.03% 16.57% 0.65x 2.23x CHF282.08 Million
2021 21.14% 22.33% 0.44x 2.16x CHF306.20 Million
2022 26.92% 19.29% 0.60x 2.32x CHF407.95 Million
2023 29.27% 17.32% 0.67x 2.51x CHF426.26 Million
2024 24.33% 16.57% 0.63x 2.34x CHF353.96 Million
2025 20.28% 13.98% 0.65x 2.22x CHF274.04 Million

Industry Comparison

This section compares Sonova H Ag's net assets metrics with peer companies in the Medical Devices industry.

No peer company data available for comparison.